• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Their Alzheimer’s treatment worked — but shares fell anyway

cafead

Administrator
Staff member
  • cafead   Aug 29, 2024 at 11:12: AM
via In the Alzheimer’s treatment market, a win can become a loss very quickly, and a loss can become a win. Even the experts have lessons to learn. For Cognition Therapeutics, getting this balance right has been complicated.

article source
 

<